Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국

Benzinga

Benzinga Korea 한국
수요일, 9월 02

argenx SE

ARGXNASDAQ
Trade with Public
Trade with Public
$1045.66
17.151.67%
마지막 업데이트: Sep 2, 2:48 PM
인수합병: Forte Biosciences (FBRX) was acquired by argenx (ARGX) on Thursday, August 27, 2026
개요뉴스실적 전망이벤트목표가재무심리지분 현황비교옵션주식 보고서

argenx Financials

argenx (ARGX) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Earnings Scheduled For July 23, 2026

Companies Reporting Before The Bell • Altisource Portfolio (NASDAQ:ASPS) is estimated to report quarterly earnings at $0.18 per share on revenue of $42.90 million. • Dime Commercial (NYSE:DCOM) is expected to report
Benzinga Insights

PRO
argenx Q2 EPS $7.32 Beats $6.24 Estimate, Sales $1.542B Beat $1.442B Estimate

argenx (NASDAQ:ARGX) reported quarterly earnings of $7.32 per share which beat the analyst consensus estimate of $6.24 by 17.31 percent. This is a 95.72 percent increase over earnings of $3.74 per share from the same
Benzinga Newsdesk

PRO
argenx Q1 EPS $5.52 Beats $5.42 Estimate, Sales $1.313B Miss $1.314B Estimate

argenx (NASDAQ:ARGX) reported quarterly earnings of $5.52 per share which beat the analyst consensus estimate of $5.42 by 1.85 percent. This is a 113.95 percent increase over earnings of $2.58 per share from the same
Benzinga Newsdesk

These Analysts Revise Their Forecasts On Argenx After Q4 Earnings

Avi Kapoor

Argenx Touts Positive Phase 3 Eye Disease Study Results

Argenx reports positive Phase 3 results for Vyvgart in eye disease, beats earnings as sales surge over 70%.
Vandana Singh

Earnings Scheduled For February 26, 2026

Benzinga Insights

데이터 및 API: Benzinga API · 주식 뉴스 API · 애널리스트 등급 API · 회사 로고 API

Benzinga

Benzinga Korea 한국

뉴스

파트너 / 기고자

벤징가 글로벌

© 2026 Benzinga | All Rights Reserved